{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:26:00Z","timestamp":1779182760196,"version":"3.51.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Varicella-zoster virus (VZV), a highly infectious agent that causes varicella (chickenpox), can also cause zoster (shingles), a disorder that is frequently associated with severe neuralgia. A reliable serological VZV diagnostic assay would be useful for identifying unprotected individuals and for surveilling post-vaccination immunoprotection status. Toward this goal, VZV membrane glycoprotein E (gE), the immunodominant VZV protein, served as target antigen in an indirect ELISA kit developed here to detect anti-VZV antibodies in clinical samples. For target antigen preparation, Chinese hamster ovary (CHO) cells were modified to express and secrete the VZV gE ectodomain, which was subsequently purified and used as coating antigen in an indirect ELISA. Ultimately, the optimal purified gE coating antigen concentration was determined to be 2\u2009\u03bcg.ml<jats:sup>\u22121<\/jats:sup> and the OD<jats:sub>450nm<\/jats:sub> detection cutoff value was 0.286. The coefficient of variation (CV) of intra-assay and inter-assay were &amp;lt;10 and 15%, respectively. A comparative test of 66 clinical samples showed that the coincidence rate was 93.9% between the indirect ELISA and a commercial varicella-zoster virus IgG ELISA kit. Thus, the indirect ELISA kit developed here may be useful for achieving rapid, sensitive, and specific detection of anti-VZV antibodies.<\/jats:p>","DOI":"10.3389\/fmicb.2022.897752","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T10:23:36Z","timestamp":1651055016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Development of an Indirect ELISA Kit for Rapid Detection of Varicella-Zoster Virus Antibody by Glycoprotein E"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan","family":"Niu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xifang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.ajic.2015.05.027","article-title":"Clinical and economic impact of various strategies for varicella immunity screening and vaccination of health care personnel","volume":"43","author":"Baracco","year":"2015","journal-title":"Am. J. Infect. Control"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"9481","DOI":"10.1128\/JVI.00533-06","article-title":"Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection","volume":"80","author":"Berarducci","year":"2006","journal-title":"J. Virol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/82_2010_9","article-title":"VZV molecular epidemiology","volume":"342","author":"Breuer","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.lpm.2014.04.001","article-title":"Varicella-zoster virus and pregnancy","volume":"43","author":"Charlier","year":"2014","journal-title":"Presse Med."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/bit.27247","article-title":"Oxidative stress-alleviating strategies to improve recombinant protein production in CHO cells","volume":"117","author":"Chevallier","year":"2020","journal-title":"Biotechnol. Bioeng."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2010_10","article-title":"The varicella-zoster virus genome","volume":"342","author":"Cohen","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1099\/0022-1317-67-9-1759","article-title":"The complete DNA sequence of varicella-zoster virus","volume":"67","author":"Davison","year":"1986","journal-title":"J. Gen. Virol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/infdis\/157.1.211","article-title":"Rapid enzyme-linked immunosorbent assay for detecting antibody to varicella-zoster virus","volume":"157","author":"Demmler","year":"1988","journal-title":"J. Infect. Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1016\/j","article-title":"Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice","volume":"30","author":"Dendouga","year":"2012","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1503\/cmaj.091711","article-title":"The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study","volume":"182","author":"Drolet","year":"2010","journal-title":"CMAJ"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/jgm.1505","article-title":"Efficient replication and generation of recombinant bovine adenovirus-3 in nonbovine cotton rat lung cells expressing I-SceI endonuclease","volume":"12","author":"Du","year":"2010","journal-title":"J. Gene Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/82_2010_12","article-title":"Perspectives on vaccines against varicella-zoster virus infections","volume":"342","author":"Gershon","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/jmv.20754","article-title":"The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection","volume":"78","author":"Hammond","year":"2006","journal-title":"J. Med. Virol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1086\/338832","article-title":"Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women","volume":"185","author":"Harger","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-1702(95)01270-2","article-title":"Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells","volume":"40","author":"Haumont","year":"1996","journal-title":"Virus Res."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"ofaa274","DOI":"10.1093\/ofid\/ofaa274","article-title":"Preventing varicella-zoster: advances with the recombinant zoster vaccine","volume":"7","author":"Ilyas","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1086\/514256","article-title":"Baculovirus expression, purification, and properties of varicella-zoster virus gE, gI, and the complex they form","volume":"178","author":"Kimura","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3324\/haematol.2011.052597","article-title":"Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation","volume":"97","author":"Kleemann","year":"2012","journal-title":"Haematologica"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1007\/s00253-016-7821-0","article-title":"Evaluation of immunity to varicella zoster virus with a novel double antigen sandwich enzyme-linked immunosorbent assay","volume":"100","author":"Liu","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1007\/s00253-015-6602-5","article-title":"A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine","volume":"99","author":"Liu","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1128\/CVI.13.2.214-218.2006","article-title":"Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay","volume":"13","author":"Maple","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1017\/S0950268816000595","article-title":"The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay","volume":"144","author":"Maple","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults","volume":"208","author":"Mullane","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/rmv.502","article-title":"Molecular studies of varicella zoster virus","volume":"16","author":"Quinlivan","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1128\/JCM.00719-06","article-title":"Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen","volume":"44","author":"Sauerbrei","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995-2000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jinf.2008.03.004","article-title":"Chickenpox in adults\u2014clinical management","volume":"57","author":"Tunbridge","year":"2008","journal-title":"J. Infect."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jmv.1890320310","article-title":"Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen","volume":"32","author":"Wasmuth","year":"1990","journal-title":"J. Med. Virol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","article-title":"Molecular mechanisms of varicella zoster virus pathogenesis","volume":"12","author":"Zerboni","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on health care utilization","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.897752\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T10:23:40Z","timestamp":1651055020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.897752\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":32,"alternative-id":["10.3389\/fmicb.2022.897752"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.897752","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"article-number":"897752"}}